Pacira BioSciences, Inc.PCRXNASDAQ
Loading
Year-over-year total asset growth rate
Percentile
P21
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -2.52% |
| Q3 2025 | -15.59% |
| Q2 2025 | -3.11% |
| Q1 2025 | 2.13% |
| Q4 2024 | 2.09% |
| Q3 2024 | -7.60% |
| Q2 2024 | 4.01% |
| Q1 2024 | 0.57% |
| Q4 2023 | 2.60% |
| Q3 2023 | -0.51% |
| Q2 2023 | 1.24% |
| Q1 2023 | -9.39% |
| Q4 2022 | -3.07% |
| Q3 2022 | 0.02% |
| Q2 2022 | -8.33% |
| Q1 2022 | -8.86% |
| Q4 2021 | 53.05% |
| Q3 2021 | 2.28% |
| Q2 2021 | 2.97% |
| Q1 2021 | 1.02% |
| Q4 2020 | 4.45% |
| Q3 2020 | 40.89% |
| Q2 2020 | 5.45% |
| Q1 2020 | -1.17% |
| Q4 2019 | 2.92% |
| Q3 2019 | 2.49% |
| Q2 2019 | 9.55% |
| Q1 2019 | 4.32% |
| Q4 2018 | 4.60% |
| Q3 2018 | 2.55% |
| Q2 2018 | 3.32% |
| Q1 2018 | -1.01% |
| Q4 2017 | 3.68% |
| Q3 2017 | 0.06% |
| Q2 2017 | 0.96% |
| Q1 2017 | 53.26% |
| Q4 2016 | 2.71% |
| Q3 2016 | -4.88% |
| Q2 2016 | 2.43% |
| Q1 2016 | 0.41% |